FDA approves zuranolone, first pill for postpartum depression
The Food and Drug Administration announced Friday it has approved the first oral treatment for postpartum depression. The drug, called zuranolone, is a once-a-day pill that will be branded as Zurzuvae by drugmakers Sage Therapeutics and Biogen. Zuranolone is approved for use in adults for the treatment of postpartum depression, an episode of major depression … Read more